ATE483163T1 - Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv - Google Patents

Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv

Info

Publication number
ATE483163T1
ATE483163T1 AT06760823T AT06760823T ATE483163T1 AT E483163 T1 ATE483163 T1 AT E483163T1 AT 06760823 T AT06760823 T AT 06760823T AT 06760823 T AT06760823 T AT 06760823T AT E483163 T1 ATE483163 T1 AT E483163T1
Authority
AT
Austria
Prior art keywords
apolipoprotein
measuring
sample
apoa
tumors
Prior art date
Application number
AT06760823T
Other languages
English (en)
Inventor
Hans Dieplinger
Florian Kronenberg
Original Assignee
Vitateq Biotechnology Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitateq Biotechnology Gmbh filed Critical Vitateq Biotechnology Gmbh
Application granted granted Critical
Publication of ATE483163T1 publication Critical patent/ATE483163T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06760823T 2005-08-08 2006-08-08 Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv ATE483163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0133305A AT502227B1 (de) 2005-08-08 2005-08-08 Verfahren zur diagnose von tumoren
PCT/AT2006/000336 WO2007016716A1 (en) 2005-08-08 2006-08-08 Method for diagnosing tumors by measuring the level of apolipoprotein a-iv

Publications (1)

Publication Number Publication Date
ATE483163T1 true ATE483163T1 (de) 2010-10-15

Family

ID=37238046

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0133305A AT502227B1 (de) 2005-08-08 2005-08-08 Verfahren zur diagnose von tumoren
AT06760823T ATE483163T1 (de) 2005-08-08 2006-08-08 Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0133305A AT502227B1 (de) 2005-08-08 2005-08-08 Verfahren zur diagnose von tumoren

Country Status (8)

Country Link
US (1) US20100136583A1 (de)
EP (1) EP1913396B1 (de)
JP (1) JP2009505039A (de)
AT (2) AT502227B1 (de)
AU (1) AU2006279237A1 (de)
CA (1) CA2614474A1 (de)
DE (1) DE602006017228D1 (de)
WO (1) WO2007016716A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105899953B (zh) 2013-11-05 2018-09-18 新加坡科技研究局 膀胱癌生物标志物
JPWO2019167874A1 (ja) 2018-02-27 2021-03-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 Ａｐｏａ４に対するモノクローナル抗体、免疫学的測定方法及び測定用キット

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3564668B2 (ja) * 1995-09-15 2004-09-15 シグネット・ラボラトリーズ・インコーポレイテッド 体液中のアポリポタンパク質ｄレベルの測定による前立腺ガンのスクリーニング方法
CA2385480A1 (en) * 1999-09-24 2001-03-29 Human Genome Sciences, Inc. 32 human secreted proteins
US20060094007A1 (en) * 2002-05-22 2006-05-04 Fujisawa Pharmaceutical Co., Ltd Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
ES2217931B1 (es) * 2002-07-01 2006-02-16 Universidad De Barcelona Metodo de diagnostico de la evolucion de la masa intestinal absortiva en un individuo.
EP1540010B8 (de) * 2002-08-06 2010-07-14 The Johns Hopkins University Verwendung von biomarkern zum nachweis von eierstockkrebs
DE10343815A1 (de) * 2003-09-22 2005-04-14 B.R.A.H.M.S Ag Verfahren zur Diagnose von Erkrankungen unter Bestimmung von Apolipoprotein C-I, und dessen Verwendung in der Therapie von Erkrankungen

Also Published As

Publication number Publication date
DE602006017228D1 (de) 2010-11-11
AU2006279237A1 (en) 2007-02-15
US20100136583A1 (en) 2010-06-03
AT502227A1 (de) 2007-02-15
CA2614474A1 (en) 2007-02-15
WO2007016716A1 (en) 2007-02-15
JP2009505039A (ja) 2009-02-05
EP1913396A1 (de) 2008-04-23
AT502227B1 (de) 2007-08-15
EP1913396B1 (de) 2010-09-29

Similar Documents

Publication Publication Date Title
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2319941A3 (de) Methode und vorrichtung zur korrelation von biomarker produktmengen mit krankheiten
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
NZ628843A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
RU2008101660A (ru) Способ диагностики болезни альцгеймера
GB2478441A (en) Lung cancer biomarkers and uses thereof
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
EP3156925A3 (de) Copd-biomarkersignaturen
RU2008103988A (ru) Способ диагностики рассеяного склероза
DE60315151D1 (de) Diagnostischer test zur bestimmung der konzentration einer transienten proteolytischen aktivität in zusammengesetzten biologischen medien
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE602006015727D1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
ATE483163T1 (de) Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
ATE495267T1 (de) Diagnostisches verfahren zum nachweis von helicobacter pylori
NZ703055A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE455297T1 (de) Mikrosensor zur bestimmung von d-aminosäuren
DE602006018038D1 (de) Molekulares verfahren zur diagnose von prostatakrebs
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties